Metraipolis › archive › dc_40f8bcb80b0e

Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review — Europe PMC PMID:42195096

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42195096
DOI
10.3390/medicina62050843
License (as archived)
solo-consultazione
Archived
2026-10-08T14:52:40.372Z
SHA-256 of the archived text
dfa3a73bb80e6fcf068608eb9d5f888d5f002d8d9f5970974ad0912934b00a42
Stable URL of this page
https://metraipolis.com/documento/dc_40f8bcb80b0e

How to cite

Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review — Europe PMC PMID:42195096 — Europe PMC (en), https://europepmc.org/article/MED/42195096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40f8bcb80b0e (Metraipolis archive dc_40f8bcb80b0e, sha256 dfa3a73bb80e6fcf068608eb9d5f888d5f002d8d9f5970974ad0912934b00a42)
BibTeX
@misc{dc40f8bcb80b0e,
  title = {Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review — Europe PMC PMID:42195096},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195096},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40f8bcb80b0e; sha256 dfa3a73bb80e6fcf068608eb9d5f888d5f002d8d9f5970974ad0912934b00a42},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195096. Agents can read the archived copy with the MCP tool read_document.